4SC discovers and develops small molecule drugs for the treatment of cancer and autoimmune disease.
Business Model:
Revenue: $0
Employees: 51-200
Address: Am Klopferspitz 19a
City: Martinsried Planegg
State: bavaria
Zip: 82152
Country: DE
4SC discovers and develops small molecule drugs for the treatment of cancer and autoimmune disease.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2008 | Nexigen | Funding Round | - |
11/2015 | Panoptes Pharma | Seed Round | - |
11/2015 | Panoptes Pharma | Seed Round | - |
5/2008 | Nexigen | Funding Round | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2002 | Grant | $2.2M | 7/2015 | Equity | $31.9M |
Wellington Partners |
7/2015 | Post-IPO Equity | 2 | $32.1M |
Santo Holding Wellington Partners Santo Holding Wellington Partners |
12/2000 | Series B | 5 | $15M |
3i Group Bayern Kapital Beteiligungsgesellschaft Neue Länder BioM AG Deutsche Venture Capital 3i Group Bayern Kapital Beteiligungsgesellschaft Neue Länder BioM AG Deutsche Venture Capital |
11/2019 | Post-IPO Equity | $24.7M | 6/2019 | Post-IPO Equity | $12.5M | 10/2000 | Grant | $1.1M | 8/1999 | Seed Round | $2.9M | 5/2003 | Series C | 4 | $10.5M |
3i Group BionX™ Medical Technologies Deutsche Venture Capital Mulligan BioCapital 3i Group BionX™ Medical Technologies Deutsche Venture Capital Mulligan BioCapital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|